Innate Pharma S.A. (IPHA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innate Pharma S.A.

    NASDAQ: IPHA · Real-Time Price · USD
    2.02
    0.01 (0.50%)
    At close: Oct 03, 2025, 3:58 PM
    2.03
    0.50%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Innate Pharma S.A. Balance Sheet Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 66.4M 70.61M 84.22M 103.76M
    Short-Term Investments
    		 14.37M 21.85M 17.26M 16.08M
    Long-Term Investments
    		 10.28M 9.8M 35.12M 39.88M
    Other Long-Term Assets
    		 9.9M 1.64M 14.25M 29.97M
    Receivables
    		 1.64M 46.49M 3.14M 1.66M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a 27.88M 11.81M
    Total Current Assets
    		 85.74M 148.01M 139.83M 138.26M
    Property-Plant & Equipment
    		 5.13M 6.32M 8.54M 10.17M
    Goodwill & Intangibles
    		 n/a 416K 1.56M 44.19M
    Total Long-Term Assets
    		 25.32M 27.18M 68.03M 129.24M
    Total Assets
    		 111.06M 175.19M 207.86M 267.5M
    Account Payables
    		 7.92M 8.56M 13.66M 14.73M
    Deferred Revenue
    		 616K 5.87M 6.56M 12.5M
    Short-Term Debt
    		 8.44M 8.45M 1.26M 29.94M
    Other Current Liabilities
    		 7.65M 7.82M 19.02M 21.91M
    Total Current Liabilities
    		 32.98M 39.64M 41.34M 79.89M
    Long-Term Debt
    		 22.18M 30.61M 38.93M 11.49M
    Other Long-Term Liabilities
    		 44.13M 39.07M 55.74M 36.23M
    Total Long-Term Liabilities
    		 69.24M 83.65M 112.37M 80.17M
    Total Liabilities
    		 102.22M 132.29M 153.71M 160.06M
    Total Debt
    		 31M 39.89M 42.25M 44.25M
    Book Value
    		 8.83M 42.9M 54.15M 107.44M
    Book Value Per Share
    		 0.11 0.51 0.68 1.35
    Common Stock
    		 4.19M 4.04M 4.01M 3.98M
    Retained Earnings
    		 -386.36M -336.89M -330.32M -272.21M
    Comprehensive Income
    		 27K 495K 819K 456K
    Shareholders Equity
    		 8.83M 51.9M 54.15M 107.44M
    Total Investments
    		 24.66M 31.65M 52.38M 55.96M

    Add to Watchlist